Chang H. Park

6.0k total citations
19 papers, 1.1k citations indexed

About

Chang H. Park is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Chang H. Park has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Chang H. Park's work include Advanced Radiotherapy Techniques (4 papers), Blood properties and coagulation (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Chang H. Park is often cited by papers focused on Advanced Radiotherapy Techniques (4 papers), Blood properties and coagulation (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Chang H. Park collaborates with scholars based in United States, South Korea and Germany. Chang H. Park's co-authors include A. Tulinsky, Robert Huber, W Kisiel, Dale T. Blankenship, K. Padmanabhan, Wolfram Bode, A D Cardin, Ewa Skrzypczak‐Jankun, Stephen K. Tahir and Boryeu Mao and has published in prestigious journals such as Molecular Cell, Journal of Molecular Biology and Biochemistry.

In The Last Decade

Chang H. Park

18 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chang H. Park United States	13	483	459	208	205	134	19	1.1k
Steven P. Leytus United States	14	508 1.1×	387 0.8×	206 1.0×	178 0.9×	139 1.0×	19	1.2k
Quoc D. Dang United States	13	368 0.8×	534 1.2×	188 0.9×	119 0.6×	52 0.4×	13	915
Ty E. Adams United Kingdom	16	273 0.6×	602 1.3×	169 0.8×	183 0.9×	57 0.4×	20	915
Eric B. Springman United States	15	479 1.0×	234 0.5×	142 0.7×	434 2.1×	348 2.6×	25	1.1k
Anzhi Wei United States	14	428 0.9×	222 0.5×	167 0.8×	228 1.1×	121 0.9×	25	861
David G. Sanford United States	16	854 1.8×	212 0.5×	94 0.5×	168 0.8×	418 3.1×	30	1.6k
Günter Krause Germany	17	793 1.6×	121 0.3×	322 1.5×	159 0.8×	152 1.1×	45	1.3k
R. Tokuoka Japan	8	563 1.2×	225 0.5×	83 0.4×	403 2.0×	135 1.0×	11	935
Uwe Jacob Germany	24	1.3k 2.6×	181 0.4×	109 0.5×	205 1.0×	236 1.8×	29	2.0k
Kenneth H. Aoki United States	12	591 1.2×	553 1.2×	84 0.4×	47 0.2×	216 1.6×	14	1.3k

Countries citing papers authored by Chang H. Park

Since Specialization

Citations

This map shows the geographic impact of Chang H. Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang H. Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang H. Park more than expected).

Fields of papers citing papers by Chang H. Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang H. Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang H. Park. The network helps show where Chang H. Park may publish in the future.

Co-authorship network of co-authors of Chang H. Park

This figure shows the co-authorship network connecting the top 25 collaborators of Chang H. Park. A scholar is included among the top collaborators of Chang H. Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang H. Park. Chang H. Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Sheppard, George S., Le Wang, Lisa Hasvold, et al.. (2018). Abstract 931: Discovery of ABBV-744, a first-in-class highly BDII-selective BET bromodomain inhibitor. Cancer Research. 78(13_Supplement). 931–931.

Tahir, Stephen K., Morey L. Smith, Paul Hessler, et al.. (2017). Potential mechanisms of resistance to venetoclax and strategies to circumvent it. BMC Cancer. 17(1). 399–399. 142 indexed citations

Park, Chang H., et al.. (2010). Positive association between striatal serotonin level and abnormal involuntary movements in chronic l-DOPA-treated hemiparkinsonian rats. Brain Research Bulletin. 84(2). 151–156. 20 indexed citations

Bruncko, Milan, Stephen K. Tahir, Xiaohong Song, et al.. (2010). N-Aryl-benzimidazolones as novel small molecule HSP90 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(24). 7503–7506. 33 indexed citations

Park, Chang H., et al.. (2009). Guidewire cannulation increases the success rate of needle‐knife fistulotomy for difficult bile duct access. Journal of Gastroenterology and Hepatology. 25(1). 14–18. 5 indexed citations

Miyashiro, Julie M., Keith W. Woods, Chang H. Park, et al.. (2009). Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1). Bioorganic & Medicinal Chemistry Letters. 19(15). 4050–4054. 91 indexed citations

Bussiere, Dirksen E., Steven Pratt, Leonard Katz, et al.. (1998). The Structure of VanX Reveals a Novel Amino-Dipeptidase Involved in Mediating Transposon-Based Vancomycin Resistance. Molecular Cell. 2(1). 75–84. 69 indexed citations

Padmanabhan, K., A. Tulinsky, Chang H. Park, et al.. (1993). Structure of Human Des(1-45) Factor Xa at 2·2 Å Resolution. Journal of Molecular Biology. 232(3). 947–966. 350 indexed citations

Park, Chang H., et al.. (1992). A graph-aided inference browser for developing knowledge-based systems. 333–339. 1 indexed citations

10.

Nath, Ravinder, et al.. (1990). A dose computation model for ²⁴¹Am vaginal applicators including the source‐to‐source shielding effects. Medical Physics. 17(5). 833–842. 16 indexed citations

11.

Soriano-Garcı́a, M., Chang H. Park, A. Tulinsky, Kirubhagaran Ravichandran, & Ewa Skrzypczak‐Jankun. (1989). Structure of calcium prothrombin fragment 1 including the conformation of the Gla domain. Biochemistry. 28(17). 6805–6810. 68 indexed citations

12.

Tulinsky, A., et al.. (1988). Lysine/fibrin binding sites of kringles modeled after the structure of kringle 1 of prothrombin. Proteins Structure Function and Bioinformatics. 3(2). 85–96. 75 indexed citations

13.

Nath, Ravinder, Richard E. Peschel, Chang H. Park, & James J. Fischer. (1988). Development of an 24Am applicator for intracavitary irradiation of gynecologic cancers. International Journal of Radiation Oncology*Biology*Physics. 14(5). 969–978. 14 indexed citations

14.

Tulinsky, A., Chang H. Park, & Ewa Skrzypczak‐Jankun. (1988). Structure of prothrombin fragment 1 refined at 2.8 Å resolution. Journal of Molecular Biology. 202(4). 885–901. 81 indexed citations

15.

Motta, Andréa, Richard A. Laursen, Miguel Llinás, A. Tulinsky, & Chang H. Park. (1987). Complete assignment of the aromatic proton magnetic resonance spectrum of the kringle 1 domain from human plasminogen: the structure of the ligand-binding site. Biochemistry. 26(13). 3827–3836. 39 indexed citations

16.

Nath, Ravinder, Laurence Gray, & Chang H. Park. (1987). Dose distributions around cylindrical ²⁴¹Am sources for a clinical intracavitary applicator. Medical Physics. 14(5). 809–817. 11 indexed citations

17.

Nath, Ravinder, et al.. (1987). Development of an 241Am applicator for continuous low-dose-rate irradiation of the rat sarcoma BA1112. International Journal of Radiation Oncology*Biology*Physics. 13(12). 1883–1892. 5 indexed citations

18.

Park, Chang H. & A. Tulinsky. (1986). Three-dimensional structure of the kringle sequence: structure of prothrombin fragment 1. Biochemistry. 25(14). 3977–3982. 110 indexed citations

19.

Park, Chang H., et al.. (1982). Crystal and molecular structure of a 14-.pi.-electron macrocyclic gold(III) complex. Inorganic Chemistry. 21(4). 1681–1682. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact